Procesamiento y usos del polvo de crema en la vida diaria
l polvo de crema es un ingrediente deshidratado de origen lácteo o vegetal que se obtiene al eliminar la humedad de la crema líquida mediante procesos como el secado por aspersión. Se utiliza en la preparación de alimentos para mejorar la textura, el sabor y la estabilidad durante el almacenamiento. Su capacidad para disolverse fácilmente en líquidos lo hace adecuado para bebidas, productos de panadería y mezclas instantáneas.
Se incorpora con frecuencia en sopas, salsas, postres y bebidas a base de café gracias a su practicidad y larga vida útil. La ausencia de agua reduce el riesgo de crecimiento microbiano, lo que permite conservarlo en condiciones normales durante más tiempo. Los procesos modernos de producción buscan mantener los compuestos de sabor y el valor nutricional.



Atopic dermatitis (AD) drugs are used to manage and treat atopic dermatitis, a chronic inflammatory skin condition characterized by itching, redness, dryness, and flare-ups. Treatment options are designed to reduce inflammation, relieve itching, prevent infections, and repair the skin barrier. Commonly used drugs include topical corticosteroids and calcineurin inhibitors for controlling mild to moderate symptoms, and systemic therapies such as oral corticosteroids, cyclosporine, and methotrexate for severe cases. In recent years, biologic drugs like dupilumab and tralokinumab, which target specific immune pathways, have revolutionized the management of moderate to severe atopic dermatitis by providing more targeted and effective treatment options with fewer side effects compared to traditional systemic drugs.
The choice of therapy often depends on the severity of the condition, patient age, and response to previous treatments. In addition to prescribed medications, antihistamines may be used to relieve itching, and antibiotics are sometimes necessary to treat secondary skin infections caused by scratching. The market for atopic dermatitis drugs is expanding rapidly due to the rising prevalence of the disease globally and the growing adoption of advanced biologics and Janus kinase (JAK) inhibitors like upadacitinib and abrocitinib. Research continues to focus on developing safer and more effective treatments that provide long-term disease control and improve patients’ quality of life.
Latest Published Reports by Emergen Research:
https://www.emergenresearch.com/industry-report/peracetic-acid-market
https://www.emergenresearch.com/industry-report/chemical-tankers-shipping-market
https://www.emergenresearch.com/industry-report/butyl-rubber-market
https://www.emergenresearch.com/industry-report/medical-robotic-systems-market
https://www.emergenresearch.com/industry-report/heparin-market